David Iggman1, Johan Ärnlöv2, Tommy Cederholm3, Ulf Risérus3. 1. Unit for Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden2Center for Clinical Research Dalarna, Falun, Sweden. 2. Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden4School of Health and Social Studies, Dalarna University, Falun, Sweden. 3. Unit for Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Abstract
Importance: The major polyunsaturated fatty acids in adipose tissue objectively reflect long-term dietary intake, and may provide more reliable information than would self-reported intake. Whether adipose tissue fatty acids predict cardiovascular and all-cause mortality needs investigation. Objective: To investigate associations between adipose tissue fatty acids and cardiovascular and overall mortality in a cohort of elderly men. Design, Setting, and Participants: We hypothesized that polyunsaturated fatty acids reflecting dietary intake, are inversely associated with cardiovascular and all-cause mortality. In the Swedish cohort study Uppsala Longitudinal Cohort of Adult Men, buttock fatty acid composition was analyzed by gas-liquid chromatography in 1992 to 1993 and 2008. The study participants were followed during 11 311 person-years, between 1991 and 2011 (median follow-up, 14.8 years). In this community-based study that took place from 1970 to 1973, all men born in 1920 to 1924 in Uppsala, Sweden, were invited and 2322 (82%) were included (at age 50 years). At the reinvestigation at age 71 years, 1221 (73%) of the 1681 invited men participated. Adipose tissue biopsy specimens were taken in a subsample of 853 men. There was no loss to follow-up. Exposures: Adipose tissue proportions of 4 polyunsaturated fatty acids that were considered to mainly reflect dietary intake (linoleic acid, 18:2n-6; α-linolenic acid, 18:3n-3; eicosapentaenoic acid, 20:5n-3; and docosahexaenoic acid, 22:6n-3) comprised primary analyses, and all other available fatty acids were secondary analyses. Main Outcomes and Measures: Hazard ratios (HRs) for cardiovascular and all-cause mortality using Cox proportional hazards regression analyses, performed in 2015. Results: Among the 853 Swedish men, there were 605 deaths, of which 251 were cardiovascular deaths. After adjusting for risk factors, none of the 4 primary fatty acids were associated with cardiovascular mortality (HR, 0.92-1.05 for each standard deviation increase; P ≥ .27). Linoleic acid was inversely associated with all-cause mortality (HR, 0.90; 95% CI, 0.82-0.98; P = .02) and directly associated with intake (P < .001). In secondary analyses, palmitoleic acid, 16:1n-7 (HR, 1.11; 95% CI, 1.02-1.21; P = .02) was associated with higher all-cause mortality, whereas heptadecanoic acid, 17:0, tended to be associated with lower all-cause mortality (HR, 0.89; 95% CI, 0.79-1.00; P = .05). Arachidonic:linoleic acid ratio was associated with both cardiovascular (HR, 1.15; 95% CI, 1.05-1.31; P = .04) and all-cause (HR, 1.13; 95% CI, 1.04-1.23; P = .005) mortality. Conclusions and Relevance: Adipose tissue linoleic acid was inversely associated with all-cause mortality in elderly men, although not significantly with cardiovascular mortality.
Importance: The major polyunsaturated fatty acids in adipose tissue objectively reflect long-term dietary intake, and may provide more reliable information than would self-reported intake. Whether adipose tissue fatty acids predict cardiovascular and all-cause mortality needs investigation. Objective: To investigate associations between adipose tissue fatty acids and cardiovascular and overall mortality in a cohort of elderly men. Design, Setting, and Participants: We hypothesized that polyunsaturated fatty acids reflecting dietary intake, are inversely associated with cardiovascular and all-cause mortality. In the Swedish cohort study Uppsala Longitudinal Cohort of Adult Men, buttock fatty acid composition was analyzed by gas-liquid chromatography in 1992 to 1993 and 2008. The study participants were followed during 11 311 person-years, between 1991 and 2011 (median follow-up, 14.8 years). In this community-based study that took place from 1970 to 1973, all men born in 1920 to 1924 in Uppsala, Sweden, were invited and 2322 (82%) were included (at age 50 years). At the reinvestigation at age 71 years, 1221 (73%) of the 1681 invited men participated. Adipose tissue biopsy specimens were taken in a subsample of 853 men. There was no loss to follow-up. Exposures: Adipose tissue proportions of 4 polyunsaturated fatty acids that were considered to mainly reflect dietary intake (linoleic acid, 18:2n-6; α-linolenic acid, 18:3n-3; eicosapentaenoic acid, 20:5n-3; and docosahexaenoic acid, 22:6n-3) comprised primary analyses, and all other available fatty acids were secondary analyses. Main Outcomes and Measures: Hazard ratios (HRs) for cardiovascular and all-cause mortality using Cox proportional hazards regression analyses, performed in 2015. Results: Among the 853 Swedish men, there were 605 deaths, of which 251 were cardiovascular deaths. After adjusting for risk factors, none of the 4 primary fatty acids were associated with cardiovascular mortality (HR, 0.92-1.05 for each standard deviation increase; P ≥ .27). Linoleic acid was inversely associated with all-cause mortality (HR, 0.90; 95% CI, 0.82-0.98; P = .02) and directly associated with intake (P < .001). In secondary analyses, palmitoleic acid, 16:1n-7 (HR, 1.11; 95% CI, 1.02-1.21; P = .02) was associated with higher all-cause mortality, whereas heptadecanoic acid, 17:0, tended to be associated with lower all-cause mortality (HR, 0.89; 95% CI, 0.79-1.00; P = .05). Arachidonic:linoleic acid ratio was associated with both cardiovascular (HR, 1.15; 95% CI, 1.05-1.31; P = .04) and all-cause (HR, 1.13; 95% CI, 1.04-1.23; P = .005) mortality. Conclusions and Relevance: Adipose tissue linoleic acid was inversely associated with all-cause mortality in elderly men, although not significantly with cardiovascular mortality.
Authors: Matti Marklund; Jason H Y Wu; Fumiaki Imamura; Liana C Del Gobbo; Amanda Fretts; Janette de Goede; Peilin Shi; Nathan Tintle; Maria Wennberg; Stella Aslibekyan; Tzu-An Chen; Marcia C de Oliveira Otto; Yoichiro Hirakawa; Helle Højmark Eriksen; Janine Kröger; Federica Laguzzi; Maria Lankinen; Rachel A Murphy; Kiesha Prem; Cécilia Samieri; Jyrki Virtanen; Alexis C Wood; Kerry Wong; Wei-Sin Yang; Xia Zhou; Ana Baylin; Jolanda M A Boer; Ingeborg A Brouwer; Hannia Campos; Paulo H M Chaves; Kuo-Liong Chien; Ulf de Faire; Luc Djoussé; Gudny Eiriksdottir; Naglaa El-Abbadi; Nita G Forouhi; J Michael Gaziano; Johanna M Geleijnse; Bruna Gigante; Graham Giles; Eliseo Guallar; Vilmundur Gudnason; Tamara Harris; William S Harris; Catherine Helmer; Mai-Lis Hellenius; Allison Hodge; Frank B Hu; Paul F Jacques; Jan-Håkan Jansson; Anya Kalsbeek; Kay-Tee Khaw; Woon-Puay Koh; Markku Laakso; Karin Leander; Hung-Ju Lin; Lars Lind; Robert Luben; Juhua Luo; Barbara McKnight; Jaakko Mursu; Toshiharu Ninomiya; Kim Overvad; Bruce M Psaty; Eric Rimm; Matthias B Schulze; David Siscovick; Michael Skjelbo Nielsen; Albert V Smith; Brian T Steffen; Lyn Steffen; Qi Sun; Johan Sundström; Michael Y Tsai; Hugh Tunstall-Pedoe; Matti I J Uusitupa; Rob M van Dam; Jenna Veenstra; W M Monique Verschuren; Nick Wareham; Walter Willett; Mark Woodward; Jian-Min Yuan; Renata Micha; Rozenn N Lemaitre; Dariush Mozaffarian; Ulf Risérus Journal: Circulation Date: 2019-05-21 Impact factor: 29.690
Authors: T Plötz; B Krümmel; A Laporte; A Pingitore; S J Persaud; A Jörns; M Elsner; I Mehmeti; S Lenzen Journal: Nutr Diabetes Date: 2017-12-21 Impact factor: 5.097
Authors: Matti Marklund; Andrew P Morris; Anubha Mahajan; Erik Ingelsson; Cecilia M Lindgren; Lars Lind; Ulf Risérus Journal: Nutrients Date: 2018-11-17 Impact factor: 5.717
Authors: Fumiaki Imamura; Amanda M Fretts; Matti Marklund; Andres V Ardisson Korat; Wei-Sin Yang; Maria Lankinen; Waqas Qureshi; Catherine Helmer; Tzu-An Chen; Jyrki K Virtanen; Kerry Wong; Julie K Bassett; Rachel Murphy; Nathan Tintle; Chaoyu Ian Yu; Ingeborg A Brouwer; Kuo-Liong Chien; Yun-Yu Chen; Alexis C Wood; Liana C Del Gobbo; Luc Djousse; Johanna M Geleijnse; Graham G Giles; Janette de Goede; Vilmundur Gudnason; William S Harris; Allison Hodge; Frank Hu; Albert Koulman; Markku Laakso; Lars Lind; Hung-Ju Lin; Barbara McKnight; Kalina Rajaobelina; Ulf Riserus; Jennifer G Robinson; Cecilia Samieri; Mackenzie Senn; David S Siscovick; Sabita S Soedamah-Muthu; Nona Sotoodehnia; Qi Sun; Michael Y Tsai; Tomi-Pekka Tuomainen; Matti Uusitupa; Lynne E Wagenknecht; Nick J Wareham; Jason H Y Wu; Renata Micha; Rozenn N Lemaitre; Dariush Mozaffarian; Nita G Forouhi Journal: PLoS Med Date: 2020-06-12 Impact factor: 11.069
Authors: Hao Yu Chen; Benjamin J Cairns; Aeron M Small; Hannah A Burr; Athithan Ambikkumar; Andreas Martinsson; Sébastien Thériault; Hans Markus Munter; Brian Steffen; Richard Zhang; Rebecca T Levinson; Christian M Shaffer; Jian Rong; Emily Sonestedt; Line Dufresne; Johan Ljungberg; Ulf Näslund; Bengt Johansson; Dilrini K Ranatunga; Rachel A Whitmer; Matthew J Budoff; Albert Nguyen; Ramachandran S Vasan; Martin G Larson; William S Harris; Scott M Damrauer; Ken D Stark; S Matthijs Boekholdt; Nicholas J Wareham; Philippe Pibarot; Benoit J Arsenault; Patrick Mathieu; Vilmundur Gudnason; Christopher J O'Donnell; Jerome I Rotter; Michael Y Tsai; Wendy S Post; Robert Clarke; Stefan Söderberg; Yohan Bossé; Quinn S Wells; J Gustav Smith; Daniel J Rader; Mark Lathrop; James C Engert; George Thanassoulis Journal: JAMA Cardiol Date: 2020-06-01 Impact factor: 30.154